Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapy

Tabuse Hiroyuki; Kashiwagi Hiroya; Hamauchi Satoshi; Tsushima Takahiro; Todaka Akiko; Yokota Tomoya; Machida Nozomu; Yamazaki Kentaro; Fukutomi Akira; Onozawa Yusuke; Mori Keita; Boku Narikazu; Ichinose Masao; Yasui Hirofumi

首页> 外文期刊>Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association >Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapy

【24h】

Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapy

机译：接受S-1化疗的胃癌患者过度浇水

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Watering eyes is a common late adverse event associated with S-1 chemotherapy; however, the frequency and predictive factors are not known.

机译：浇水是与S-1化疗相关的常见晚期不良事件。但是，频率和预测因素尚不清楚。

著录项

来源
《Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association》 |2016年第3期|共8页
作者
Tabuse Hiroyuki; Kashiwagi Hiroya; Hamauchi Satoshi; Tsushima Takahiro; Todaka Akiko; Yokota Tomoya; Machida Nozomu; Yamazaki Kentaro; Fukutomi Akira; Onozawa Yusuke; Mori Keita; Boku Narikazu; Ichinose Masao; Yasui Hirofumi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Adverse event; Chemotherapy; Gastric cancer; S-1; Watering eyes;

机译：不良事件;化学疗法;胃癌;S-1;浇水;
入库时间 2022-08-18 11:03:12

相似文献

外文文献
中文文献
专利

1. Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapy [J] . Tabuse Hiroyuki, Kashiwagi Hiroya, Hamauchi Satoshi, Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association . 2016,第3期

机译：接受S-1化疗的胃癌患者过度浇水
2. Lacrimal drainage obstruction in gastric cancer patients receiving S-1 chemotherapy [J] . N. Kim1 C. Park2 D. J. Park3 H.-H. Kim3 S. Kim45 Y. J. Kim4 J. H. Kim4 J. S. Lee4 Y.-J. Bang5 S. I. Khwarg2 H. Choung6 M. J. Lee7 and K.-W. Lee4* Annals of Oncology . 2012,第8期

机译：接受S-1化疗的胃癌患者的泪道引流阻塞
3. Inflammation-based prognostic score predicts survival in patients with advanced gastric cancer receiving biweekly docetaxel and s-1 combination chemotherapy [J] . KunisakiC., TakahashiM., OnoH.A., Oncology: International Journal of Cancer Research and Treatment . 2012,第4期

机译：基于炎症的预后评分可预测接受双周多西紫杉醇和s-1联合化疗的晚期胃癌患者的生存率
4. S-1/CDDP/Lentinan Combination Chemotherapy for Inoperable Advanced Gastric Cancer [C] . Shoichi Nagahashi, Hidekazu Suzuki, Toshifumi Hib International Gastric Cancer Congress . 2005

机译：S-1 / CDDP / Lentinan组合化疗，可管理的胃癌无法操作
5. Treatment Patterns and Cost-Effectiveness of Chemotherapy Treatments among Advanced Gastric Cancer Patients [D] . Haag, Austin Jade. 2017

机译：晚期胃癌患者化学疗法的治疗模式和成本效益
6. A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine [O] . Keun-Wook Lee, Bum Jun Kim, Mi-Jung Kim, 2017

机译：多西他赛与多西他赛加顺铂与多西他赛加S-1作为转移性胃癌患者顺铂加S-1或卡培他滨治疗后的二线化疗的多中心随机II期研究
7. Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer [O] . 2017

机译：胃癌S-1辅助化疗试验中的胰岛素样生长因子-1受体和双调蛋白表达对II / III期胃癌患者生存的影响

Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅